Regulatory disclosures and commitments for Orphalan UK Ltd
Published in accordance with UK legislation and industry codes of practice, these documents reflect our commitment to transparency, sustainability and ethical conduct.
Orphalan UK Ltd. has taken steps to understand all potential modern slavery risks related to its business, in accordance with Section 54 of the UK Modern Slavery Act 2015.
We are committed to preventing slavery and human trafficking, both in our own corporate activities and our supply chain. We take measures to ensure that all of our contractors, suppliers and business partners comply with the same high standards.
Orphalan UK is committed to achieving Net Zero emissions by 2045. Click here to access the report.
Orphalan UK is committed to ensuring any interactions between the pharmaceutical industry and healthcare professionals (HCP), healthcare organisations (HCO) and patient organisations (PO) meet the high standards of professionalism, integrity and transparency that are expected.